rss
J Clin Pathol 2003;56:873-875 doi:10.1136/jcp.56.11.873
  • Short report

Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia

  1. J R Kerr1,
  2. F Barah2,
  3. V S Cunniffe1,
  4. J Smith3,
  5. P J Vallely2,
  6. A M Will4,
  7. R F Wynn4,
  8. R F Stevens4,
  9. G M Taylor5,
  10. G M Cleator2,
  11. O B Eden4
  1. 1Department of Microbiology, Royal Brompton Hospital, Imperial College London, Sydney Street, London SW3 6NP, UK
  2. 2Department of Virology, University of Manchester, M13 9WL, UK
  3. 3Tissue Typing, Harefield Hospital, Middlesex, UB9 6JH, UK
  4. 4Department of Paediatric Haematology/Oncology, Central Manchester and Manchester Children’s University Hospital Trusts, Manchester M20 4BX, UK
  5. 5Department of Immunogenetics, Central Manchester and Manchester Children’s University Hospital Trusts, Manchester M13 9WL, UK
  1. Correspondence to:
 Dr J R Kerr
 Department of Microbiology, Royal Brompton Hospital, Imperial College London, Sydney Street, London SW3 6NP, UK; j.kerric.ac.uk
  • Accepted 17 May 2003

Abstract

Aims: To investigate the association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia.

Methods: Cerebrospinal fluid (CSF) samples from patients with acute myelogenous leukaemia (AML) at diagnosis (n = 2) and acute lymphoblastic leukaemia (ALL) at diagnosis (n = 14) were analysed for parvovirus B19 DNA by means of nested polymerase chain reaction. In addition, samples from patients with benign intracranial hypertension (BIH) (n = 10) and hydrocephalus (n = 13) were tested as controls.

Results: Four leukaemia cases were positive—common ALL (n = 2), null cell ALL (n =1), and M7 AML (n = 1)—whereas all controls were negative (Yates corrected χ2 value, 3.97; p = 0.046; odds ratio, 16.92; confidence interval, 1.03 to 77.18). All four patients were significantly anaemic, but none was encephalitic or had evidence of central nervous system leukaemia. In three of these patients, serum tumour necrosis α, interferon γ, interleukin 6, granulocyte–macrophage colony stimulating factor (range, 34.93–3800.06pg/ml), and macrophage chemoattractant protein 1 were detectable. All of these four patients carried at least one of the HLA-DRB1 alleles, which have been associated with symptomatic parvovirus B19 infection.

Conclusion: Erythroid suppression and immune cell proliferation are both associated with B19 infection and may also be important in the pathogenesis of acute leukaemia.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.